- Home
- FTFT vs ALBT Comparison
FTFT vs ALBT Comparison
Compare FTFT & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ALBT
- Stock Information
- Founded
- FTFT N/A
- ALBT 2014
- Country
- FTFT United States
- ALBT United States
- Employees
- FTFT N/A
- ALBT N/A
- Industry
- FTFT Business Services
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTFT Consumer Discretionary
- ALBT Health Care
- Exchange
- FTFT Nasdaq
- ALBT Nasdaq
- Market Cap
- FTFT 5.9M
- ALBT 5.7M
- IPO Year
- FTFT N/A
- ALBT N/A
- Fundamental
- Price
- FTFT $1.15
- ALBT $2.73
- Analyst Decision
- FTFT
- ALBT
- Analyst Count
- FTFT 0
- ALBT 0
- Target Price
- FTFT N/A
- ALBT N/A
- AVG Volume (30 Days)
- FTFT 48.8K
- ALBT 87.1K
- Earning Date
- FTFT 08-18-2025
- ALBT 08-18-2025
- Dividend Yield
- FTFT N/A
- ALBT N/A
- EPS Growth
- FTFT N/A
- ALBT N/A
- EPS
- FTFT N/A
- ALBT N/A
- Revenue
- FTFT $2,031,913.00
- ALBT $807,235.00
- Revenue This Year
- FTFT N/A
- ALBT N/A
- Revenue Next Year
- FTFT N/A
- ALBT N/A
- P/E Ratio
- FTFT N/A
- ALBT N/A
- Revenue Growth
- FTFT N/A
- ALBT N/A
- 52 Week Low
- FTFT $1.01
- ALBT $2.11
- 52 Week High
- FTFT $5.70
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- FTFT 39.32
- ALBT 54.02
- Support Level
- FTFT $1.01
- ALBT $2.65
- Resistance Level
- FTFT $1.16
- ALBT $3.79
- Average True Range (ATR)
- FTFT 0.09
- ALBT 0.27
- MACD
- FTFT 0.01
- ALBT 0.05
- Stochastic Oscillator
- FTFT 25.00
- ALBT 65.85
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.